AR054823A1 - Sales de tetrazol bifenilo carboxaldehido - Google Patents

Sales de tetrazol bifenilo carboxaldehido

Info

Publication number
AR054823A1
AR054823A1 ARP060102936A ARP060102936A AR054823A1 AR 054823 A1 AR054823 A1 AR 054823A1 AR P060102936 A ARP060102936 A AR P060102936A AR P060102936 A ARP060102936 A AR P060102936A AR 054823 A1 AR054823 A1 AR 054823A1
Authority
AR
Argentina
Prior art keywords
carboxaldehido
bifenyl
tetrazol
salts
salt
Prior art date
Application number
ARP060102936A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR054823A1 publication Critical patent/AR054823A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Reivindicacion 1: Un proceso o método para la fabricacion de una sal de un aldehído de la formula (1), o un tautomero del mismo, en donde [Kat]n+ es un cation, y n es 1, 2, 3, 4, 5, o 6, el cual comprende formar y aislar esta sal a partir de una solucion que comprende un compuesto de la formula (1), y un material que proporciona cationes.
ARP060102936A 2005-07-11 2006-07-07 Sales de tetrazol bifenilo carboxaldehido AR054823A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0514206.2A GB0514206D0 (en) 2005-07-11 2005-07-11 Organic compounds

Publications (1)

Publication Number Publication Date
AR054823A1 true AR054823A1 (es) 2007-07-18

Family

ID=34897057

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102936A AR054823A1 (es) 2005-07-11 2006-07-07 Sales de tetrazol bifenilo carboxaldehido

Country Status (30)

Country Link
US (1) US7728024B2 (es)
EP (1) EP1912956B1 (es)
JP (1) JP2009500434A (es)
KR (1) KR20080030609A (es)
CN (2) CN101208313A (es)
AR (1) AR054823A1 (es)
AT (1) ATE504577T1 (es)
AU (1) AU2006268906B2 (es)
BR (1) BRPI0613129A2 (es)
CA (1) CA2614718A1 (es)
DE (1) DE602006021187D1 (es)
EC (1) ECSP088090A (es)
ES (1) ES2363439T3 (es)
GB (1) GB0514206D0 (es)
GT (1) GT200600303A (es)
IL (1) IL188190A0 (es)
MA (1) MA29633B1 (es)
MX (1) MX2008000465A (es)
MY (1) MY143947A (es)
NO (1) NO20080742L (es)
NZ (1) NZ564548A (es)
PE (1) PE20070248A1 (es)
PL (1) PL1912956T3 (es)
PT (1) PT1912956E (es)
RU (1) RU2435761C2 (es)
SA (1) SA06270220B1 (es)
TN (1) TNSN08005A1 (es)
TW (1) TW200745065A (es)
WO (1) WO2007006531A1 (es)
ZA (1) ZA200711023B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008004110A2 (en) 2006-07-03 2008-01-10 Aurobindo Pharma Limited Process for the preparation of the angiotensin ii antagonist valsartan
EP2260018A2 (en) 2008-04-07 2010-12-15 Hetero Research Foundation Process for preparation of valsartan intermediate
CN103012301B (zh) * 2013-01-05 2015-06-17 江苏施美康药业股份有限公司 缬沙坦甲酯碱金属盐及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
JP4568400B2 (ja) * 2000-03-24 2010-10-27 株式会社日本ファインケム 水和ヒドラジンとジシアンを原料とする5,5’−ビ−1h−テトラゾールジアンモニウム塩の製造方法
GB0222056D0 (en) 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
EP1660463B1 (en) * 2003-08-08 2007-12-05 Dipharma Francis S.r.l. A process for the preparation of phenyltetrazole derivatives
ITMI20032267A1 (it) 2003-11-21 2005-05-22 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procdimento per la preparzione di valsartan e suoi intermedi

Also Published As

Publication number Publication date
NZ564548A (en) 2011-08-26
IL188190A0 (en) 2008-03-20
US7728024B2 (en) 2010-06-01
NO20080742L (no) 2008-02-11
GT200600303A (es) 2007-03-28
AU2006268906A1 (en) 2007-01-18
PE20070248A1 (es) 2007-04-12
RU2435761C2 (ru) 2011-12-10
SA06270220B1 (ar) 2009-11-15
JP2009500434A (ja) 2009-01-08
CN101208313A (zh) 2008-06-25
ECSP088090A (es) 2008-02-20
ZA200711023B (en) 2008-12-31
CA2614718A1 (en) 2007-01-18
PL1912956T3 (pl) 2011-09-30
RU2008104526A (ru) 2009-08-20
PT1912956E (pt) 2011-06-09
US20080234490A1 (en) 2008-09-25
MA29633B1 (fr) 2008-07-01
DE602006021187D1 (de) 2011-05-19
BRPI0613129A2 (pt) 2010-12-21
TW200745065A (en) 2007-12-16
KR20080030609A (ko) 2008-04-04
ES2363439T3 (es) 2011-08-04
WO2007006531A1 (en) 2007-01-18
TNSN08005A1 (en) 2009-07-14
AU2006268906B2 (en) 2010-07-29
CN101468972A (zh) 2009-07-01
GB0514206D0 (en) 2005-08-17
EP1912956B1 (en) 2011-04-06
MX2008000465A (es) 2008-03-11
EP1912956A1 (en) 2008-04-23
ATE504577T1 (de) 2011-04-15
MY143947A (en) 2011-07-29

Similar Documents

Publication Publication Date Title
ECSP055913A (es) Inhibidores de las polimerasas víricas
PE20190374A1 (es) Combinacion farmaceutica de un antagonista del receptor de angiotensina y un inhibidor de endopeptidasa neutra
GT201000114A (es) "mezclas fungicidas"
CO6220968A2 (es) Inhibidores heterociclicos de la aspartil proteasa
CL2012002526A1 (es) Uso de compuestos inhibidores de dpp iv de formula (i) o (ii) o una de sus sales, para el tratamiento de falla cardiaca.
ECSP11006282A (es) Proceso para la preparación de derivados de tetrazol a partir de azidas de organo-boro y de organo-aluminio
WO2012127183A8 (en) Treatment fluids containing a biodegradable chelating agent and methods for use thereof
CR11151A (es) Sales del inhibidor de janus cinasa (r)-3-(4-(7h-pirrolo[2,3-ciclopentilpropanitrilo
PA8680201A1 (es) Proceso de elaboración para tigeciclina
CL2009001993A1 (es) Compuestos derivados de 6-oxo-4-fenilamino-1,6-dihidropiridina-3-amida, inhibidores de mek; proceso de preparacion de estos, utiles en el tratamiento de un trastorno hiperproliferativo o una condicion inflamatoria. (divisional de la solicitud cl 1168-06)
AR057874A1 (es) Aminopirimidinas utiles como inhibidores de quinasa
ECSP24006831A (es) Inhibidores de cdk2
MA29539B1 (fr) Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one
CL2008002089A1 (es) Compuesto para la regeneracion de tejidos que comprende al menos una sustancia derivada de sangre y acido hialuronico y/o al menos un compuesto derivado de acido hialuronico; metodo para la prepararcion de dicho compuesto.
BRPI1010804A2 (pt) "método para fabricação de carbodiimidas"
AR055761A1 (es) Procedimiento para preparar especies de aluminio
PE20231308A1 (es) Proceso e intermedios para preparar un inhibidor de jak1
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
AR058019A1 (es) Proceso de preparacion de un derivado de pirrolopirimidina
AR054823A1 (es) Sales de tetrazol bifenilo carboxaldehido
PE20090166A1 (es) Sales de adicion de acido, hidratos y polimorfos de la etil-amida del acido 5-(2,4-dihidroxi-5-isopropil-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxilico, y formulaciones que comprenden estas formas
BRPI0802215A2 (pt) mÉtodo de fabricaÇço de uma espuma de aspersço de poliisocianurato/poliuretano
DOP2023000277A (es) Pirimidinil-pirazoles sustituidos como inhibidores de cdk2
CL2019002499A1 (es) Protodescarboxilación catalizada por metales de transición de derivados de ácido a-halo-acrílico.
UY29115A1 (es) Un procedimiento para fabricar compuestos enantiomericos del imidazol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal